You are currently visiting our International webshop, visitors from the UK, ES, NL, BE, DE and FR. Please make sure you choose the correct webshop of your country, scroll down the page to choose the correct store. If your country is not available in the dropdown below you can shop at the international website. Thank you!

Triamhexal 10mg 5 Amp. x 1 ml

Expiry date:
Registration number:
DE: ZNR 6403867.00.00

Is the registration number of your country not listed? Then this product falls within the cascade control system.

For alleviating the joint pain, swelling and stiffness
More info

Disclaimer: Product in the photo may differ from the actual product.

Intra-articular use: for alleviating the joint pain, swelling and stiffness associated with rheumatoid arthritis and osteoarthrosis, with an inflammatory component; also for bursitis, epicondylitis, and tenosynovitis.

Intramuscular use: Where sustained systemic corticosteroid treatment is required: Allergic states, e.g. bronchial asthma, seasonal or perennial allergic rhinitis. In seasonal allergies, patients who do not respond to conventional therapy may achieve a remission of symptoms over the entire period with a single intramuscular injection (see Dosage); Endocrine disorders, e.g. primary or secondary adrenocortical insufficiency. Collagen disorders, e.g. during an exacerbation of maintenance therapy of selected cases of SLE or acute rheumatic carditis; Dermatological diseases, e.g. pemphigus, severe dermatitis and Stevens Johnson Syndrome; Rheumatic, Gastrointestinal or Respiratory disorders - as an adjunctive, short-term therapy; Haematological disorders, e.g. acquired (autoimmune) haemolytic anaemia; Neoplastic diseases, e.g. palliative management of leukaemia and lymphomas; Renal disease, such as acute interstitial nephritis, minimal change nephrotic syndrome or lupus nephritis.

Dosage and administration
Intra-Articular Injection: For intra-articular administration or injection into tendon sheaths and bursae, 2.5 to 15mg, subcutaneous or direct  Injection  up to 40mg (1.0ml) for larger joints, depending on the specific disease entity being treated. Single injections into several sites for multiple joint involvement, up to a total of 80mg, have been given without undue reactions.

Adults and Children over 12 Years: The suggested initial dose is 40mg (1.0ml) injected deeply into the upper, outer quadrant of the gluteal muscle. Subsequent dosage depends on the patient's response and period of relief. Patients with hay fever or pollen asthma who do not respond to conventional therapy may obtain a remission of symptoms lasting throughout the pollen season after a single dose of 40-100mg given when allergic symptoms appear.

Children from 6-12 Years of Age: 2.5 to 15 ml which might be repeated if needed.


© 2023 Grovet B.V. All rights reserved.